Heat shock protein 70, erythropoietin, and cancer

J Clin Oncol. 2007 Sep 20;25(27):4326; author reply 4326-7. doi: 10.1200/JCO.2007.13.0419.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Carcinoma / drug therapy
  • Carcinoma / metabolism*
  • Disease Progression
  • Erythropoietin / adverse effects*
  • Erythropoietin / therapeutic use
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic*
  • HSP70 Heat-Shock Proteins / biosynthesis*
  • HSP70 Heat-Shock Proteins / physiology*
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / metabolism*
  • Humans
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Receptors, Erythropoietin / metabolism*
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • HSP70 Heat-Shock Proteins
  • Receptors, Erythropoietin
  • Recombinant Proteins
  • Erythropoietin